Livent Co., (NYSE:LTHM – Free Report), was the beneficiary of an unusually high volume of options trading on Monday. Stock traders purchased 5,351 puts on the stock. This is an increase of 64% over the average volume (3,258 put options).
Inflows of Institutional Capital and Outflows
Recent changes in institutional investments and hedge funds have seen them increase or decrease their stakes. Great Valley Advisor Group Inc. increased its holdings of shares of Livent in the fourth quarter by 14.6%. Great Valley Advisor Group Inc. owns 54 469 shares worth $1 082,000, after buying 6,948 additional shares in the last quarter. GSA Capital Partners LLP has increased its shares of Livent holdings by 25.8% in the fourth quarter. GSA Capital Partners LLP owns 20,147 of the company’s shares worth $400 after purchasing 4,134 additional shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its stake in Livent shares by 225.0% during the fourth quarter. Connor Clark & Lunn Investment Management Ltd. owns 47.229 shares valued at $938,000. This is after acquiring 32,698 additional shares in the last quarter. BlackRock Inc. increased its stake in Livent shares by 8.3% during the third quarter. BlackRock Inc. owns now 28,159,121 of the company’s stock, valued at $863.078,000, after purchasing an additional 2,156.474 shares in the last quarter. Evergreen Capital Management LLC also acquired shares of Livent during the third quarter, valued at approximately $270,000. 95.82% is owned by institutional investors.
Get Livent alerts:
Analysts set new price targets
A number of equity research analysts have made comments on the stock. CICC Research upgraded the shares of Livent in a research report on Thursday, 5th May from a rating of'market perform to an outperform rating. B. Riley upgraded Livent shares from a neutral' to a buy' rating in a research report on Thursday, 11th May. The stock was given a price target of $32.00. Raymond James lowered their price target for shares of Livent to $30 from $35.00 in a research report on Wednesday, 4/5. They also gave the stock an 'outperform rating'. Deutsche Bank Aktiengesellschaft increased their price target for shares of Livent on Thursday, April 20, from $23.00 up to $25.00. The company was also given a "hold" rating. In a research report published on May 4th, Mizuho lowered their price target for shares of Livent, from $30.00 down to $29.00. Six analysts gave the company a buy recommendation, while five research analysts rated it as a hold. According to MarketBeat data, Livent's consensus rating is 'Moderate buy' with a consensus target price of $29.80.
Livent Stocks Up by 2.8 %
LTHM shares rose $0.78 in midday trading Monday to $28.21. The trading volume was 2,066,051 compared to the average of 3,140.124. Livent's 1 year low is $18.26, and its 1 year high is $36.38. The company's current ratio is 4.23. Its quick ratio is 2.83. And its debt-to equity ratio is 0.16. The company's market capitalization is $5.07 billion. It has a P/E of 16.93 and a PEG of 0.44. The company's 50-day moving average is $24.75 while its two-hundred-day moving average is $23.29.
The last time Livent (NYSE LTHM – Free Report) released its quarterly results was on May 2nd. The company posted $0.60 in earnings per share for the quarter. This was $0.21 higher than the consensus estimate. The company reported revenue of $235.50 for the quarter compared with analyst estimates of only $229.94. Livent's net margin was 36.30% and its return on equity was 26.15 percent. The company's revenue for the quarter was up 64.1% compared to last year. In the same quarter last year, Livent posted $0.21 in earnings per share. Analysts expect Livent to post an average of 2.05 earnings per share in the current fiscal period.
Livent Corporation is a manufacturer and seller of performance lithium compounds. These are primarily used for lithium-based batteries and specialty polymers in North America and Latin America. They also sell them in Europe, Middle East, Africa and Asia Pacific. The company provides lithium compounds that meet specific performance needs. These include battery-grade lithium hydroxide for high-performance lithium-ion cells; butyllithium for polymers and pharmaceuticals, and a variety of specialty lithium compounds.
MarketBeat.com offers a FREE daily email that summarizes the latest news about Livent, including analyst ratings.